Recently funded startups in Massachusetts, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Delix Therapeutics | Boston | Series C | $100.0M | 2026-11-09 |
| Emvolon | Woburn | Series A | $22.0M | 2026-10-27 |
| ZwitterCo | Woburn | Series C | $58.4M | 2026-10-22 |
| ASI | Boston | Series C | $325.0M | 2026-10-20 |
| Ledgebrook | Boston | Series C | $200.0M | 2026-10-07 |
| Arkea Bio | Charlestown | Series A | $15.0M | 2026-09-29 |
| UltraSight | Cambridge | Series B | $24.0M | 2026-09-23 |
| LineVision | Boston | Series D | $37.5M | 2026-09-17 |
8 rows of the CSV in 5 of its 18 columns.
- The 90 startups in Massachusetts, United States funded in the last 90 days have raised $5.3B in total.
- 90 of them closed their most recent round in the last 12 months, $2.5B combined.
- The largest of those rounds is ASI's $325.0M Series C, dated October 2026.
- The most recent is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- RA Capital Management is an investor in 2 of them, more than any other fund.
- Software is the most common sector, with 46 companies (51%).
- 79% were founded in 2020 or later; the median founding year is 2024.
- The most common team size is 1 to 10 employees (52% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 90| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn | Series A | $22.0M | 2026-10-27 | $24.5M | National Science Foundation, MassVentures, The Engine | 11 to 50 | 2021 |
| ASI | ASI develops AI software for managing complex physical operations in aviation, defense, energy, and logistics. | Artificial intelligence | Boston | Series C | $325.0M | 2026-10-20 | $359.4M | Andreessen Horowitz, Village Global, Gradient +2 | 101 to 250 | 2018 |
| Ledgebrook | Ledgebrook provides excess and surplus insurance solutions through wholesale brokers. | Artificial intelligence | Boston | Series C | $200.0M | 2026-10-07 | $314.8M | Brand Foundry Ventures, Markd, American Family Ventures +2 | 251 to 500 | 2021 |
| Arkea Bio | Arkea Bio develops technology that reduces greenhouse gas emissions from agriculture. | Biotech | Charlestown | Series A | $15.0M | 2026-09-29 | $60.5M | Breakthrough Energy Ventures, Overview, Rabo Ventures | 11 to 50 | 2021 |
| UltraSight | UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. | Health care | Cambridge | Series B | $24.0M | 2026-09-23 | $39.0M | Yozma Group | 11 to 50 | 2018 |
| LineVision | LineVision provides utilities with monitoring and analytics that improve grid capacity, resilience, and safety. | Artificial intelligence | Boston | Series D | $37.5M | 2026-09-17 | $87.3M | S2G Investments, National Grid Partners (NGP), Clean Energy Venture Group +2 | 51 to 100 | 2018 |
| Alzheon | Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. | Biotech | Framingham | Series F | $78.8M | 2026-09-10 | $343.3M | Ally Bridge Group, National Institute on Aging | 11 to 50 | 2013 |
| INIA Biosciences | INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. | Biotech | Boston | Seed | $1.5M | 2026-09-08 | $1.5M | MassChallenge, MedTech Innovator | 1 to 10 | 2020 |
| Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Boston | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| Locus Robotics Unicorn | Locus Robotics manufactures autonomous mobile robots that support warehouse e-commerce operations. | Artificial intelligence | Wilmington | Series G | $41.6M | 2026-09-01 | $463.7M | Tiger Global Management, Scale Venture Partners, Bond +2 | 251 to 500 | 2014 |
| Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Cambridge | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 | 51 to 100 | 2019 |
Table 1. Recently funded startups in Massachusetts, United States: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 90.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ASI | ASI develops AI software for managing complex physical operations in aviation, defense, energy, and logistics. | Artificial intelligence | Boston | Series C | $325.0M | 2026-10-20 | $359.4M | Andreessen Horowitz, Village Global, Gradient +2 | 101 to 250 | 2018 |
| 2 | Ledgebrook | Ledgebrook provides excess and surplus insurance solutions through wholesale brokers. | Artificial intelligence | Boston | Series C | $200.0M | 2026-10-07 | $314.8M | Brand Foundry Ventures, Markd, American Family Ventures +2 | 251 to 500 | 2021 |
| 3 | Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| 4 | Alzheon | Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. | Biotech | Framingham | Series F | $78.8M | 2026-09-10 | $343.3M | Ally Bridge Group, National Institute on Aging | 11 to 50 | 2013 |
| 5 | Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Boston | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| 6 | Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Cambridge | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 | 51 to 100 | 2019 |
| 7 | Locus Robotics Unicorn | Locus Robotics manufactures autonomous mobile robots that support warehouse e-commerce operations. | Artificial intelligence | Wilmington | Series G | $41.6M | 2026-09-01 | $463.7M | Tiger Global Management, Scale Venture Partners, Bond +2 | 251 to 500 | 2014 |
| 8 | LineVision | LineVision provides utilities with monitoring and analytics that improve grid capacity, resilience, and safety. | Artificial intelligence | Boston | Series D | $37.5M | 2026-09-17 | $87.3M | S2G Investments, National Grid Partners (NGP), Clean Energy Venture Group +2 | 51 to 100 | 2018 |
| 9 | UltraSight | UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. | Health care | Cambridge | Series B | $24.0M | 2026-09-23 | $39.0M | Yozma Group | 11 to 50 | 2018 |
| 10 | Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn | Series A | $22.0M | 2026-10-27 | $24.5M | National Science Foundation, MassVentures, The Engine | 11 to 50 | 2021 |
Table 2. Recently funded startups in Massachusetts, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator | Boston, United States | 2 | 2% | 2 | Delix Therapeutics, Superluminal Medicines |
| 2 | MassVentures | Venture capital firm | Boston, United States | 2 | 2% | 2 | Emvolon, ZwitterCo |
| 3 | Gaingels | Syndicate | Burlington, United States | 1 | 1% | 1 | Delix Therapeutics |
| 4 | Casa Verde Capital | Venture capital firm | Los Angeles, United States | 1 | 1% | 1 | Delix Therapeutics |
| 5 | Artis Ventures | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | Delix Therapeutics |
| 6 | Dolby Family Ventures | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | Delix Therapeutics |
| 7 | The Engine | Venture capital firm | Cambridge, United States | 1 | 1% | 1 | Emvolon |
| 8 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 1 | 1% | 1 | Emvolon |
| 9 | US Department of Energy | Government investment office | Washington, United States | 1 | 1% | 1 | ZwitterCo |
| 10 | DCVC | Venture capital firm | Palo Alto, United States | 1 | 1% | 1 | ZwitterCo |
| 11 | Village Global | Micro VC fund | Covina, United States | 1 | 1% | 1 | ASI |
| 12 | XYZ Venture Capital | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | ASI |
| 13 | Franklin Templeton | Private equity firm | San Mateo, United States | 1 | 1% | 1 | ASI |
| 14 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 1 | 1% | 1 | ASI |
| 15 | Gradient | Venture capital firm | San Francisco, United States | 1 | 1% | 1 | ASI |
Table 3. Recently funded startups in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 46 | 51% | $2.5B |
| Artificial intelligence | 39 | 43% | $2.4B |
| Health care | 36 | 40% | $2.8B |
| Biotech | 28 | 31% | $2.6B |
| Hardware | 19 | 21% | $1.2B |
| Energy | 8 | 9% | $411.9M |
| Fintech | 7 | 8% | $376.8M |
| Commerce | 5 | 6% | $43.4M |
| Education | 1 | 1% | $970K |
Table 4. Recently funded startups in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Recently funded startups in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Boston | 40 | 44% |
| Cambridge | 19 | 21% |
| Woburn | 6 | 7% |
| Andover | 3 | 3% |
| Newton | 3 | 3% |
| Watertown | 2 | 2% |
| Framingham | 2 | 2% |
| Somerville | 2 | 2% |
| Chelmsford | 1 | 1% |
| Winchester | 1 | 1% |
| Westwood | 1 | 1% |
| Brookline | 1 | 1% |
Table 6. Recently funded startups in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 12 | 13% | $301.3M |
| October 2026 | 26 | 29% | $1.3B |
| September 2026 | 37 | 41% | $719.5M |
| August 2026 | 15 | 17% | $191.5M |
Table 7. Recently funded startups in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 90 | 100% | $2.5B |
Table 8. Recently funded startups in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 50 | 57% |
| 2020 to 2022 | 19 | 22% |
| 2015 to 2019 | 15 | 17% |
| 2010 to 2014 | 2 | 2% |
| Before 2010 | 1 | 1% |
Table 9. Recently funded startups in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 45 | 52% |
| 11 to 50 | 29 | 33% |
| 51 to 100 | 6 | 7% |
| 101 to 250 | 5 | 6% |
| 251 to 500 | 2 | 2% |
Table 10. Recently funded startups in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is dated in the 90 days to 16 November 2026 and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 90 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 90 rows: 9 have no round amount, 0 no city and 2 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many startups in Massachusetts, United States funded in the last 90 days are on the list?
- 90, in the file dated 16 November 2026. 90 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 90 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.